Lei ZHAO
Academic / Other · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular HCC | Phase 2 | 2025-12-28 |
| Recruiting | Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Intrahepatic Cholangiocarcinoma | Phase 2 | 2024-03-01 |
| Recruiting | Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Rese HCC | Phase 2 | 2023-10-25 |